Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
92.46 CHF | +0.15% | +5.13% | +8.97% |
May. 10 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
May. 10 | Novartis Gets FDA Breakthrough Therapy Designation for Scemblix | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.97% | 208B | |
+30.38% | 684B | |
+29.74% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.28% | 240B | |
-7.61% | 200B | |
+7.68% | 166B | |
-2.71% | 159B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Sector Update: Health Care Stocks Rise Late Afternoon